Submit Deal

Announced

30 Jan 2020

Completed

30 Jan 2020

SoftBank led a Series D funding round for Alto Pharmacy.

Synopsis

SoftBank led a Series D funding round for Alto Pharmacy, a drug delivery firm. Other existing investors, including Greenoaks Capital and Jackson Square Ventures, also participated in the round.

Principals

target

Alto Pharmacy

bidder

Greenoaks Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

mattieu gamache-asselin

CEO at ALTO PHARMACY

Manager

target

Deals

£ 149 M

Total Value

jamie karraker

Founder and Chief Technology Officer at ALTO PHARMACY

Manager

target

Deals

£ 149 M

Total Value

Bidder Team (10)

neil mehta

Founding Partner at GREENOAKS CAPITAL

Investor

bidder

Deals

£ 9.79 B

Total Value

marcelo claure

CEO of SoftBank Group International at SOFTBANK GROUP CORP

Manager

bidder

Deals

£ 62.11 B

Total Value

ronald d fisher

Vice Chairman at SOFTBANK GROUP CORP

Manager

bidder

Deals

£ 662 M

Total Value

ronald d fisher

Vice Chairman at SOFTBANK GROUP CORP

Manager

bidder

Deals

£ 662 M

Total Value

masayoshi son

Chairman and CEO at SOFTBANK GROUP CORP

Investor

bidder

116

Deals

£ 218.58 B

Total Value

yoshimitsu goto

CFO at SOFTBANK GROUP CORP

Manager

bidder

Deals

£ 58.22 B

Total Value

jeffrey aronson

Partner at DLA Piper

Lawyer

bidder

Deals

n/a

Total Value

justin wilson

Partner at SOFTBANK GROUP CORP

Manager

bidder

Deal

n/a

Total Value

anna l. spencer

Partner at DLA Piper

Lawyer

bidder

Deals

n/a

Total Value

craig lang

Partner at DLA Piper

Lawyer

bidder

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy